Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-011525
Filing Date
2019-01-17
Accepted
2019-01-17 16:16:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(5) d644726d424b5.htm 424B5 421638
2 GRAPHIC g644726g92c43.jpg GRAPHIC 9757
  Complete submission text file 0001193125-19-011525.txt   436334
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218607 | Film No.: 19531128
SIC: 2834 Pharmaceutical Preparations